We first evaluated the protein levels of PLZF and Tyr705 phosphorylation STAT3 (pY-STAT3) in 40 prostate cancer patients and 10 benign patient tissues, which were categorized according to Gleason scores (GS). This evidence concerns the gene ZBTB16 and prostate carcinoma.